 | • レポートコード：MRC2304L036 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、世界の伴侶動物向け医療市場規模が2021年に244.5億ドル、2022年に287.2億ドルとなり、その後2027年までにCAGR 17.62％で成長して647.7億ドルに達すると予測しています。当書は、伴侶動物向け医療の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、動物別分析（猫、犬、馬）、疾患別分析（行動障害、歯科疾患、皮膚疾患、感染症、整形外科疾患）、種類別分析（薬用添加飼料、栄養飼料添加物、医薬品、ワクチン）、エンドユーザー別分析（小売薬局、動物病院）、エンドユーザー別分析（外食産業、小売顧客）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。また、当書には、Alcami Corporation、B. Braun Melsungen AG、Bayer AG、Bioiberica S.A.U.、Boehringer Ingelheim GmbH、Ceva Sante Animale S.A.、Cozmix Inc.、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、Elanco US, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の伴侶動物向け医療市場規模：動物別 - 猫における市場規模 - 犬における市場規模 - 馬における市場規模 ・世界の伴侶動物向け医療市場規模：疾患別 - 行動障害における市場規模 - 歯科疾患における市場規模 - 皮膚疾患における市場規模 - 感染症における市場規模 - 整形外科疾患における市場規模 ・世界の伴侶動物向け医療市場規模：種類別 - 薬用添加飼料の市場規模 - 栄養飼料添加物の市場規模 - 医薬品の市場規模 - ワクチンの市場規模 ・世界の伴侶動物向け医療市場規模：エンドユーザー別 - 小売薬局における市場規模 - 動物病院における市場規模 ・世界の伴侶動物向け医療市場規模：地域別 - 南北アメリカの伴侶動物向け医療市場規模 アメリカの伴侶動物向け医療市場規模 カナダの伴侶動物向け医療市場規模 ブラジルの伴侶動物向け医療市場規模 ... - アジア太平洋の伴侶動物向け医療市場規模 日本の伴侶動物向け医療市場規模 中国の伴侶動物向け医療市場規模 インドの伴侶動物向け医療市場規模 韓国の伴侶動物向け医療市場規模 台湾の伴侶動物向け医療市場規模 ... - ヨーロッパ/中東/アフリカの伴侶動物向け医療市場規模 イギリスの伴侶動物向け医療市場規模 ドイツの伴侶動物向け医療市場規模 フランスの伴侶動物向け医療市場規模 ロシアの伴侶動物向け医療市場規模 ... - その他地域の伴侶動物向け医療市場規模 ・競争状況 ・企業情報 |
The Global Companion Animal Health Market size was estimated at USD 24.45 billion in 2021 and expected to reach USD 28.72 billion in 2022, and is projected to grow at a CAGR 17.62% to reach USD 64.77 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Companion Animal Health to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Animal, the market was studied across Cats, Dogs, and Horses.
Based on Indication, the market was studied across Behavioral Disorders, Dental Diseases, Dermatologic Diseases, Infectious Diseases, and Orthopedic Diseases.
Based on Type, the market was studied across Medicinal Additive Feed, Nutritional Feed Additives, Pharmaceuticals, and Vaccines. The Medicinal Additive Feed is further studied across Amino Acids, Minerals, and Vitamins. The Nutritional Feed Additives is further studied across Enzymes, Feed Acidifiers, Hormones, Immune Modulators, and Prebiotics & Probiotics. The Pharmaceuticals is further studied across Anti-inflammatories, Antibiotics, Ectoparasiticides, and Endoparasiticides.
Based on End User, the market was studied across Retail Pharmacies and Veterinary Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Companion Animal Health market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Health Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Health Market, including Alcami Corporation, B. Braun Melsungen AG, Bayer AG, Bioiberica S.A.U., Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Cozmix Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Elanco US, Inc., Eli Lilly and Company, IDEXX Laboratories, Inc., Medtronic PLC, Merck & Co., Inc., MSD Animal Health Srl, Nutreco N.V., Perrigo Company PLC, Vetoquinol SA, Virbac SA, and Zoetis, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Companion Animal Health Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Health Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Health Market?
4. What is the competitive strategic window for opportunities in the Global Companion Animal Health Market?
5. What are the technology trends and regulatory frameworks in the Global Companion Animal Health Market?
6. What is the market share of the leading vendors in the Global Companion Animal Health Market?
7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Health Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing initiatives by government and animal welfare associations
5.1.1.2. Technological advancements in the field of animal healthcare
5.1.1.3. Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
5.1.1.4. Increasing disposable incomes and pet owners afford to spend more on pet healthcare
5.1.1.5. Increasing online shopping and home delivery is driving the product sale
5.1.2. Restraints
5.1.2.1. Increase in cheap counterfeit drugs
5.1.2.2. Lack of infrastructure, funding, and standardization
5.1.3. Opportunities
5.1.3.1. Increase in cheap counterfeit drugs
5.1.3.2. Lack of infrastructure, funding, and standardization
5.1.4. Challenges
5.1.4.1. Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
5.1.4.2. High cost associated with animal testing and veterinary in developing countries
5.2. Cumulative Impact of COVID-19
6. Companion Animal Health Market, by Animal
6.1. Introduction
6.2. Cats
6.3. Dogs
6.4. Horses
7. Companion Animal Health Market, by Indication
7.1. Introduction
7.2. Behavioral Disorders
7.3. Dental Diseases
7.4. Dermatologic Diseases
7.5. Infectious Diseases
7.6. Orthopedic Diseases
8. Companion Animal Health Market, by Type
8.1. Introduction
8.2. Medicinal Additive Feed
8.3.1. Amino Acids
8.3.2. Minerals
8.3.3. Vitamins
8.3. Nutritional Feed Additives
8.4.1. Enzymes
8.4.2. Feed Acidifiers
8.4.3. Hormones
8.4.4. Immune Modulators
8.4.5. Prebiotics & Probiotics
8.4. Pharmaceuticals
8.5.1. Anti-inflammatories
8.5.2. Antibiotics
8.5.3. Ectoparasiticides
8.5.4. Endoparasiticides
8.5. Vaccines
9. Companion Animal Health Market, by End User
9.1. Introduction
9.2. Retail Pharmacies
9.3. Veterinary Hospitals
10. Americas Companion Animal Health Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Companion Animal Health Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Companion Animal Health Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Alcami Corporation
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. B. Braun Melsungen AG
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bayer AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bioiberica S.A.U.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Boehringer Ingelheim GmbH
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Ceva Sante Animale S.A.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Cozmix Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Dechra Pharmaceuticals PLC
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Elanco Animal Health Incorporated
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Elanco US, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Eli Lilly and Company
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. IDEXX Laboratories, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Medtronic PLC
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Merck & Co., Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. MSD Animal Health Srl
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Nutreco N.V.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Perrigo Company PLC
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Vetoquinol SA
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Virbac SA
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Zoetis, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing